European Union - English - EMA (European Medicines Agency)

ge healthcare b.v. - ioflupane (123l) - tomography, emission-computed, single-photon; lewy body disease; parkinson disease; alzheimer disease - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. datscan is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

European Union - English - EMA (European Medicines Agency)

cis bio international - ioflupane (123l) - radionuclide imaging; dementia; movement disorders - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.striascan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. striascan is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. striascan is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Singapore - English - HSA (Health Sciences Authority)

ge healthcare pte. ltd. - ioflupane (123i) - injection, solution - ioflupane (123i) 74 mbq/ml at reference time

European Union - English - EMA (European Medicines Agency)

pinax pharma gmbh - ioflupane (123i) - radionuclide imaging; dementia; movement disorders - diagnostic radiopharmaceuticals - this medicinal product is for diagnostic use only.celsunax is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum:in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. celsunax is unable to discriminate between parkinson's disease, multiple system atrophy and progressive supranuclear palsy.in adult patients, to help differentiate probable dementia with lewy bodies from alzheimer’s disease. celsunax is unable to discriminate between dementia with lewy bodies and parkinson’s disease dementia.

Israel - English - Ministry of Health

eldan electronic instruments co ltd - ioflupane - solution for injection - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - in adult patients with clinically uncertain parkinsonian syndromes, for example those with early symptoms, in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - in adult patients to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia

Canada - English - Health Canada

ge healthcare canada inc - ioflupane (123i) - solution - 74mbq - ioflupane (123i) 74mbq - roentgenography

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rotop radiopharmacy gmbh - sodium iodide (123 i) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

curium pharma uk ltd - ioflupane [i-123] - solution for injection - 74mbq/1ml

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

rotop radiopharmacy gmbh - sodium iodide (123 i) 74 mbq/ml - solution for injection - 74 mbq/ml - ioflupane (i-123) 74 mbq/ml - iodine ioflupane (123i)

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

curium pharma uk ltd - ioflupane [i-123] - solution for injection - 74mbq/1ml